Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

https://www.youtube.com/watch?v=xuTKPPZrxy4
Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
  • Home
  • 2025
  • September
  • 22
  • Stryker Launches New R&D Center in Bangalore, Boosting India’s Med-Tech Innovation
  • Industries
  • Pharma News

Stryker Launches New R&D Center in Bangalore, Boosting India’s Med-Tech Innovation

Pharm'Up 1 min read

Stryker, a global leader in medical technologies, has announced the opening of a new 140,000-square-foot R&D facility in Whitefield, Bangalore. This expansion strengthens the company’s presence in India, complementing its existing 220,000-square-foot R&D campus in Gurgaon.

The new facility is a strategic move to integrate cutting-edge technologies, including robotics, artificial intelligence (AI), digital innovation, and product security. It is designed to foster collaboration and accelerate the development of solutions that address the evolving needs of global healthcare.

A key feature of the new center is a medical experience center. This space will serve as a hub for deep collaboration with healthcare professionals, allowing them to engage with Stryker’s latest innovations firsthand. The center will showcase a range of life-saving products, from ICU beds and stretchers to ambulance cots and automated external defibrillators (AEDs).

Ram Rangarajan, Vice President of Stryker Global Technology Center, highlighted the facility’s purpose-driven growth. “The advanced labs will allow us to work closely with healthcare professionals, unlock valuable insights, and accelerate innovation,” he said. The new center aims to attract top talent and drive sustained growth while focusing on the mission of making healthcare better.

This investment in Bangalore’s dynamic ecosystem of research and talent underscores Stryker’s continued commitment to India as a key hub for medical technology innovation.

About the Author

Pharm'Up

Author

An E-platform for Pharma Learners

View All Posts

Post navigation

Previous: Indoco Remedies’ API Plant Earns a Clean Bill of Health from USFDA
Next: Dr. Reddy’s Introduces Novel Acid-Blocker Tegoprazan (PCAB®) in India to Combat Widespread Acid Peptic Diseases

Related Stories

Pharmup 1
1 min read
  • Pharma News

AstraZeneca’s Tozorakimab Marks Major Milestone in Phase III COPD Trial

Pharm'Up
Pharmup 1
1 min read
  • Pharma News

Piramal Pharma Expands Global Injectables Footprint with Kenalog® Acquisition

Pharm'Up
Pharmup 2
2 min read
  • Industries

Johnson & Johnson’s VARIPULSE Platform Shows Exceptional 12-Month Results in Massive Real-World Study

Pharm'Up

Recent Posts

  • Hepatitis A: Acute Viral Infection and Prevention
  • Hepatitis: Understanding Liver Inflammation and Its Causes
  • Liver Transplantation: A Lifesaving Procedure
  • Understanding Hemorrhoids: Causes, Symptoms, and Care
  • Hemochromatosis: Understanding Iron Overload

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharmup 21
2 min read
  • Disease

Hepatitis A: Acute Viral Infection and Prevention

Pharm'Up
Pharmup 20
1 min read
  • Disease

Hepatitis: Understanding Liver Inflammation and Its Causes

Pharm'Up
Pharmup 19
1 min read
  • Disease

Liver Transplantation: A Lifesaving Procedure

Pharm'Up
Pharmup 18
1 min read
  • Disease

Understanding Hemorrhoids: Causes, Symptoms, and Care

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.